HOWL
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. (HOWL) has 10 SEC Form 4 filings (32 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 8, 2026.
The most active filer is Director EVNIN LUKE with 18 filings. Insiders have net sold $1.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Daniel J. Hicklin
- Employees:46
- HQ:Watertown, MA, US
- IPO:2021-04-30
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$16.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 35,770 | $11K | Jul 8 | SEC ↗ | |
| Director | Sale | 107,429 | $33K | Jul 8 | SEC ↗ | |
| Director | Sale | 157,084 | $47K | Jun 29 | SEC ↗ | |
| 10% Owner | Sale | 416,911 | $146K | Jun 22 | SEC ↗ | |
| 10% Owner | Sale | 369,800 | $137K | Jun 12 | SEC ↗ | |
| 10% Owner | Sale | 45,923 | $17K | Jun 12 | SEC ↗ | |
| 10% Owner | Sale | 262,503 | $100K | Jun 12 | SEC ↗ | |
| Director | Sale | 80,459 | $38K | Jun 3 | SEC ↗ | |
| Director | Sale | 29,595 | $13K | Jun 3 | SEC ↗ | |
| Director | Sale | 29,749 | $12K | Jun 3 | SEC ↗ | |
| Director | Sale | 80,852 | $39K | May 29 | SEC ↗ | |
| Director | Sale | 27,698 | $13K | May 29 | SEC ↗ | |
| Director | Sale | 32,556 | $15K | May 29 | SEC ↗ | |
| Director | Sale | 305,741 | $214K | May 12 | SEC ↗ | |
| Director | Sale | 33,948 | $23K | May 12 | SEC ↗ | |
| Director | Sale | 67,885 | $43K | May 12 | SEC ↗ | |
| 10% Owner | Sale | 376,526 | $267K | May 12 | SEC ↗ | |
| 10% Owner | Sale | 87,490 | $59K | May 12 | SEC ↗ | |
| 10% Owner | Sale | 101,151 | $65K | May 12 | SEC ↗ | |
| Director | Sale | 6,860 | $5K | May 7 | SEC ↗ | |
| Director | Sale | 14,635 | $10K | May 7 | SEC ↗ | |
| Director | Sale | 79,086 | $50K | May 7 | SEC ↗ | |
EVNIN LUKEFirst filing | Insider | Sale | 53,940 | $46K | Apr 29 | SEC ↗ |
EVNIN LUKEFirst filing | Insider | Sale | 95,412 | $70K | Apr 29 | SEC ↗ |
EVNIN LUKEFirst filing | Insider | Sale | 56,559 | $39K | Apr 29 | SEC ↗ |
Related companies
Werewolf Therapeutics, Inc. is in the Healthcare sector.